MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 195 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $753,469 | +130.7% | 12,825 | +71.0% | 0.00% | +100.0% |
Q3 2023 | $326,656 | +11.6% | 7,499 | -7.4% | 0.00% | – |
Q2 2023 | $292,653 | -63.5% | 8,100 | -62.4% | 0.00% | -100.0% |
Q1 2023 | $801,043 | -66.3% | 21,545 | -36.6% | 0.00% | -85.7% |
Q3 2022 | $2,375,000 | -28.1% | 34,000 | -30.9% | 0.01% | -30.0% |
Q2 2022 | $3,303,000 | +331.8% | 49,200 | +429.0% | 0.01% | +400.0% |
Q1 2022 | $765,000 | -53.9% | 9,300 | -17.7% | 0.00% | -60.0% |
Q4 2021 | $1,658,000 | +44.2% | 11,300 | +73.8% | 0.01% | +25.0% |
Q3 2021 | $1,150,000 | -10.0% | 6,500 | +11.7% | 0.00% | -20.0% |
Q4 2020 | $1,278,000 | +91.0% | 5,817 | -33.1% | 0.01% | 0.0% |
Q1 2020 | $669,000 | -69.6% | 8,700 | -49.0% | 0.01% | -68.8% |
Q4 2019 | $2,198,000 | +239.7% | 17,057 | +105.5% | 0.02% | +166.7% |
Q3 2019 | $647,000 | -91.4% | 8,300 | -88.6% | 0.01% | -90.8% |
Q2 2019 | $7,509,000 | +303.3% | 72,900 | +187.0% | 0.06% | +364.3% |
Q1 2019 | $1,862,000 | +220.5% | 25,400 | +85.4% | 0.01% | +180.0% |
Q4 2018 | $581,000 | +91.7% | 13,700 | +122.6% | 0.01% | +150.0% |
Q2 2018 | $303,000 | +1162.5% | 6,155 | +71.0% | 0.00% | – |
Q3 2016 | $24,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |